{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:42:22Z","timestamp":1789990942624,"version":"4.0.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"9","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.autrev.2013.03.009","type":"journal-article","created":{"date-parts":[[2013,3,25]],"date-time":"2013-03-25T15:16:10Z","timestamp":1364224570000},"page":"894-903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Impairment of regulatory T cells in myasthenia gravis: Studies in an experimental model"],"prefix":"10.1016","volume":"12","author":[{"given":"Smadar","family":"Gertel-Lapter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keren","family":"Mizrachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Berrih-Aknin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam C.","family":"Souroujon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2013.03.009_bb0005","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1212\/WNL.27.4.307","article-title":"Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model","volume":"27","author":"Engel","year":"1977","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.009_bb0010","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1749-6632.1976.tb47676.x","article-title":"The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis. A quantitative ultrastructural study","volume":"274","author":"Engel","year":"1976","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2013.03.009_bb0015","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.009_bb0020","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.autrev.2013.03.004","article-title":"Diagnosis and therapy of myasthenia gravis with antibodies to muscle-specific kinase","volume":"12","author":"Evoli","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.009_bb0025","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.autrev.2013.03.003","article-title":"Complement Associated Pathogenic Mechanisms in Myasthenia Gravis","volume":"12","author":"T\u00fcz\u00fcn","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.009_bb0030","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.autrev.2013.03.001","article-title":"HuijbersMG, Jaap J. Plomp, Erik H, Niks PC, et al. Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4","volume":"12","author":"Verschuuren","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.009_bb0035","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.autrev.2013.03.002","article-title":"Serological diagnostics in myasthenia gravis based on novel assays and recently identified antigens","volume":"12","author":"Zisimopoulou","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.009_bb0040","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.autrev.2013.03.005","article-title":"Mechanisms associated with the pathogenicity of antibodies againstmuscle-specific kinase inmyasthenia gravis","volume":"12","author":"Mori","year":"2013","journal-title":"Autoimmun Reviews"},{"key":"10.1016\/j.autrev.2013.03.009_bb0045","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/clim.1999.4807","article-title":"Animal models of myasthenia gravis","volume":"94","author":"Christadoss","year":"2000","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2013.03.009_bb0050","series-title":"Immunological Methods Manual","first-page":"1763","article-title":"Experimental autoimmune myasthenia gravis","author":"Souroujon","year":"1997"},{"key":"10.1016\/j.autrev.2013.03.009_bb0055","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3109\/08916930903518081","article-title":"Development of novel therapies for MG: studies in animal models","volume":"43","author":"Souroujon","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2013.03.009_bb0060","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1196\/annals.1405.042","article-title":"CD4+ T cells and cytokines in the pathogenesis of acquired myasthenia gravis","volume":"1132","author":"Conti-Fine","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1016\/j.autrev.2013.03.009_bb0065","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0952-7915(00)00160-6","article-title":"Helper T cells in antibody-mediated, organ-specific autoimmunity","volume":"12","author":"Elson","year":"2000","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2013.03.009_bb0070","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.autrev.2013.03.011","article-title":"Ectopic germinal centers, BAFF and anti-B cell therapy in Myasthenia Gravis","volume":"12","author":"Berrih-Aknin","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.009_bb0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jneuroim.2010.03.016","article-title":"Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients","volume":"225","author":"Masuda","year":"2010","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.009_bb0080","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2013.03.009_bb0085","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.autrev.2010.07.003","article-title":"Interleukin-17-producing T helper cells in autoimmunity","volume":"9","author":"Hemdan","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.009_bb0090","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2013.03.009_bb0095","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.autrev.2011.06.004","article-title":"Autoimmunity in 2010","volume":"10","author":"Selmi","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.009_bb0100","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.autrev.2011.05.004","article-title":"Human FoxP3+ regulatory T cells in systemic autoimmune diseases","volume":"10","author":"Miyara","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.009_bb0105","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","article-title":"Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses","volume":"22","author":"Sakaguchi","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2013.03.009_bb0110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","article-title":"Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease","volume":"212","author":"Sakaguchi","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2013.03.009_bb0115","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.immunol.18.1.423","article-title":"Regulatory T, cells in autoimmmunity*","volume":"18","author":"Shevach","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2013.03.009_bb0120","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nri821","article-title":"CD4+ CD25+ suppressor T cells: more questions than answers","volume":"2","author":"Shevach","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2013.03.009_bb0125","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1084\/jem.20040249","article-title":"In vivo instruction of suppressor commitment in naive T cells","volume":"199","author":"Apostolou","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2013.03.009_bb0130","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25\u2212 naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2013.03.009_bb0135","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri1032","article-title":"Natural versus adaptive regulatory T cells","volume":"3","author":"Bluestone","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2013.03.009_bb0140","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2013.03.009_bb0145","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.autrev.2013.03.009_bb0150","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni909","article-title":"An essential role for Scurfin in CD4+CD25+ T regulatory cells","volume":"4","author":"Khattri","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2013.03.009_bb0155","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.0105-2896.2006.00415.x","article-title":"The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells","volume":"212","author":"Shevach","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2013.03.009_bb0160","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1172\/JCI19441","article-title":"Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25\u2212 T cells","volume":"112","author":"Walker","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2013.03.009_bb0165","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0092-8674(00)80856-9","article-title":"Regulatory T, cells: key controllers of immunologic self-tolerance","volume":"101","author":"Sakaguchi","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2013.03.009_bb0170","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/jaut.1996.0026","article-title":"T cell-mediated maintenance of natural self-tolerance: its breakdown as a possible cause of various autoimmune diseases","volume":"9","author":"Sakaguchi","year":"1996","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2013.03.009_bb0175","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm.2622","article-title":"Re-establishing immunological self-tolerance in autoimmune disease","volume":"18","author":"Sakaguchi","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2013.03.009_bb0180","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2249.2006.03173.x","article-title":"The role of CD4CD25 T cells in autoantibody production in murine lupus","volume":"145","author":"Hsu","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2013.03.009_bb0185","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.4049\/jimmunol.0901163","article-title":"Cutting edge: regulatory T cells directly suppress B cells in systemic lupus erythematosus","volume":"183","author":"Iikuni","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.03.009_bb0190","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.1987.tb51282.x","article-title":"The role of the thymus in myasthenia gravis: immunohistological and immunological studies in 115 cases","volume":"505","author":"Berrih-Aknin","year":"1987","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2013.03.009_bb0195","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/08916930903563491","article-title":"Thymic remodeling associated with hyperplasia in myasthenia gravis","volume":"43","author":"Le Panse","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2013.03.009_bb0200","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2013.03.009_bb0205","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2567.2005.02220.x","article-title":"Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment","volume":"116","author":"Fattorossi","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2013.03.009_bb0210","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0165-5728(02)00228-X","article-title":"Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence","volume":"130","author":"Wang","year":"2002","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.009_bb0215","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.4049\/jimmunol.180.4.2132","article-title":"Ex vivo generated regulatory T cells modulate experimental autoimmune myasthenia gravis","volume":"180","author":"Aricha","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.03.009_bb0220","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaut.2010.12.001","article-title":"Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis","volume":"36","author":"Aricha","year":"2011","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2013.03.009_bb0225","doi-asserted-by":"crossref","first-page":"e826","DOI":"10.1111\/j.1365-2567.2009.03089.x","article-title":"Disequilibrium of T helper type 1, 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis","volume":"128","author":"Mu","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2013.03.009_bb0230","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0019-2791(77)90291-9","article-title":"Immunochemical studies on acetylcholine receptor from Torpedo californica","volume":"14","author":"Aharonov","year":"1977","journal-title":"Immunochemistry"},{"key":"10.1016\/j.autrev.2013.03.009_bb0235","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.4049\/jimmunol.146.7.2245","article-title":"Recombinant human acetylcholine receptor alpha-subunit induces chronic experimental autoimmune myasthenia gravis","volume":"146","author":"Lennon","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.03.009_bb0240","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2005-11-4502","article-title":"Activated CD4+CD25+ T cells selectively kill B lymphocytes","volume":"107","author":"Zhao","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2013.03.009_bb0245","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/eji.200838699","article-title":"CD25+ T(reg) specifically suppress auto-Ab generation against pancreatic tissue autoantigens","volume":"39","author":"Ludwig-Portugall","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2013.03.009_bb0250","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/83784","article-title":"Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse","volume":"27","author":"Brunkow","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2013.03.009_bb0255","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nri2889","article-title":"Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases","volume":"10","author":"Buckner","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2013.03.009_bb0260","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.autrev.2013.03.006","article-title":"Novel future therapeutic options in Myasthenia Gravis","volume":"12","author":"Dalakas","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.009_bb0265","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.4049\/jimmunol.0903183","article-title":"Naturally occurring CD4+CD25+ regulatory T cells prevent but do not improve experimental myasthenia gravis","volume":"185","author":"Nessi","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.03.009_bb0270","doi-asserted-by":"crossref","first-page":"6435","DOI":"10.4049\/jimmunol.172.10.6435","article-title":"CD4+CD25 bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis","volume":"172","author":"de Kleer","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.03.009_bb0275","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4049\/jimmunol.174.1.164","article-title":"Dysfunctional blood and target tissue CD4+CD25 high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation","volume":"174","author":"Sugiyama","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.03.009_bb0280","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2013.03.009_bb0285","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1084\/jem.20032158","article-title":"Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II","volume":"199","author":"Kriegel","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2013.03.009_bb0290","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jneuroim.2007.09.034","article-title":"Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with Guillain\u2013Barre syndrome","volume":"192","author":"Chi","year":"2007","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.009_bb0295","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.4049\/jimmunol.178.4.2579","article-title":"Deficient CD4+CD25 high T regulatory cell function in patients with active systemic lupus erythematosus","volume":"178","author":"Valencia","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.03.009_bb0300","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1182\/blood.V89.9.3287","article-title":"Thymocyte Fas expression is dysregulated in myasthenia gravis patients with anti-acetylcholine receptor antibody","volume":"89","author":"Moulian","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2013.03.009_bb0305","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2008-01-133967","article-title":"Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells","volume":"112","author":"Koenen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2013.03.009_bb0310","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1073\/pnas.0900408106","article-title":"Identification of IL-17-producing FOXP3+ regulatory T cells in humans","volume":"106","author":"Voo","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2013.03.009_bb0315","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nri2660","article-title":"Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective","volume":"9","author":"Weaver","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2013.03.009_bb0320","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.4049\/jimmunol.180.8.5393","article-title":"Release from regulatory T cell-mediated suppression during the onset of tissue-specific autoimmunity is associated with elevated IL-21","volume":"180","author":"Clough","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.03.009_bb0325","doi-asserted-by":"crossref","first-page":"19857","DOI":"10.1073\/pnas.0810713105","article-title":"The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors","volume":"105","author":"D'Alise","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2013.03.009_bb0330","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.4049\/jimmunol.171.8.4040","article-title":"Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development","volume":"171","author":"Gregori","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.03.009_bb0335","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nm1564","article-title":"Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation","volume":"13","author":"Korn","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2013.03.009_bb0340","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2337\/diabetes.54.5.1415","article-title":"Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells","volume":"54","author":"You","year":"2005","journal-title":"Diabetes"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997213000359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997213000359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T14:04:01Z","timestamp":1688133841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997213000359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":68,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1568997213000359"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2013.03.009","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impairment of regulatory T cells in myasthenia gravis: Studies in an experimental model","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2013.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}